PL371319A1 - Pochodne kumaryny, sposób ich wytwarzania i ich zastosowanie - Google Patents
Pochodne kumaryny, sposób ich wytwarzania i ich zastosowanieInfo
- Publication number
- PL371319A1 PL371319A1 PL03371319A PL37131903A PL371319A1 PL 371319 A1 PL371319 A1 PL 371319A1 PL 03371319 A PL03371319 A PL 03371319A PL 37131903 A PL37131903 A PL 37131903A PL 371319 A1 PL371319 A1 PL 371319A1
- Authority
- PL
- Poland
- Prior art keywords
- production
- coumarin derivatives
- coumarin
- derivatives
- Prior art date
Links
- 150000001893 coumarin derivatives Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
- C07D311/12—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 3 and unsubstituted in position 7
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
- C07D311/18—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted otherwise than in position 3 or 7
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/94—[b, c]- or [b, d]-condensed containing carbocyclic rings other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/14—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/36—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Neurology (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002004359 | 2002-01-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL371319A1 true PL371319A1 (pl) | 2005-06-13 |
Family
ID=19190995
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL03371319A PL371319A1 (pl) | 2002-01-11 | 2003-01-09 | Pochodne kumaryny, sposób ich wytwarzania i ich zastosowanie |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20050020634A1 (pl) |
| EP (1) | EP1471064A4 (pl) |
| KR (1) | KR20040081123A (pl) |
| CN (1) | CN1615305A (pl) |
| AU (1) | AU2003202488A1 (pl) |
| CA (1) | CA2472419A1 (pl) |
| IL (1) | IL162810A0 (pl) |
| NO (1) | NO20043349L (pl) |
| NZ (1) | NZ533893A (pl) |
| PL (1) | PL371319A1 (pl) |
| WO (1) | WO2003059900A1 (pl) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070060595A1 (en) * | 2003-10-10 | 2007-03-15 | Toshio Yoshizawa | Novel fused heterocyclic compound and use thereof |
| US20050118226A1 (en) * | 2003-11-07 | 2005-06-02 | Kovacs Dora M. | Methods for treating ACAT-related diseases |
| US7157584B2 (en) | 2004-02-25 | 2007-01-02 | Takeda Pharmaceutical Company Limited | Benzimidazole derivative and use thereof |
| BRPI0508260A (pt) * | 2004-03-02 | 2007-07-31 | Takeda Pharmaceutical | sal de metal alcalino terroso ou um sal de amina orgánico de um composto, composto, processo para a produção de um sal de metal alcalino terroso de um composto, cristal, medicamento, agente para a regressão, inibição da progressão ou estabilização de uma lesão arteriosclerótica ou aterosclerótica, uso do composto |
| AR059339A1 (es) * | 2006-02-09 | 2008-03-26 | Chugai Pharmaceutical Co Ltd | Derivados de la cumarina para trastornos proliferativos de celulas, composicion farmaceutica y agente terapeutico que los contiene |
| FR2904215B1 (fr) * | 2006-07-28 | 2009-02-13 | Docteur Gaetano Zannini Soc Pa | Testeurs de parfums et parfums |
| US20080207654A1 (en) | 2006-11-24 | 2008-08-28 | Takeda Pharmaceutical Company Limited | Heteromonocyclic compound and use thereof |
| JP5484910B2 (ja) * | 2006-12-22 | 2014-05-07 | ユーハン・コーポレイション | レバプラザン含有の固体分散体及びその製造方法 |
| KR20080076440A (ko) * | 2007-02-16 | 2008-08-20 | (주)아모레퍼시픽 | 실로스타졸의 제어방출 제제 및 그 제조방법 |
| US8501750B2 (en) | 2007-05-21 | 2013-08-06 | Takeda Pharmaceutical Company Limited | Heterocyclic compound and use thereof |
| WO2009014100A1 (ja) * | 2007-07-20 | 2009-01-29 | Chugai Seiyaku Kabushiki Kaisha | ｐ２７蛋白質誘導剤 |
| CA2720343A1 (en) | 2008-04-04 | 2009-10-08 | Takeda Pharmaceutical Company Limited | Heterocyclic derivative and use thereof |
| PT2282779E (pt) * | 2008-04-29 | 2013-05-28 | Pharnext | Novas abordagens terapêuticas para o tratamento da doença de alzheimer e doenças relacionadas através de uma modulação de resposta ao stresse celular |
| WO2010056914A1 (en) * | 2008-11-12 | 2010-05-20 | Microbiotix, Inc. | Bacterial helicase inhibitor compounds and uses thereof |
| US20100190747A1 (en) | 2009-01-27 | 2010-07-29 | Hideo Suzuki | Fused ring compound and use thereof |
| US9023858B2 (en) | 2010-07-23 | 2015-05-05 | Takeda Pharmaceutical Company Limited | Substituted pyrido[2,3-d]pyrimidines as delta-5-desaturase inhibitors |
| US20150299188A1 (en) | 2012-08-24 | 2015-10-22 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
| US20160065057A1 (en) * | 2013-03-15 | 2016-03-03 | Intelligent Energy Limited | Fuel cell dc-dc converter |
| US9968604B2 (en) | 2015-04-16 | 2018-05-15 | Chiesi Farmaceutici S.P.A. | Chromene derivatives as phoshoinositide 3-kinases inhibitors |
| CN106995500A (zh) * | 2017-05-24 | 2017-08-01 | 徐学 | 一种改性海藻酸钠高分子絮凝剂的制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69315920T2 (de) * | 1992-09-04 | 1998-06-10 | Takeda Chemical Industries Ltd | Kondensierte heterozyklische Verbindungen, deren Herstellung und Verwendung |
| JP2002255808A (ja) * | 2000-07-13 | 2002-09-11 | Takeda Chem Ind Ltd | リピド・リッチ・プラーク退縮剤 |
| KR100866820B1 (ko) * | 2000-07-13 | 2008-11-04 | 다케다 야쿠힌 고교 가부시키가이샤 | 지질 풍부 플라크 퇴축제 |
| JP2002241267A (ja) * | 2000-12-11 | 2002-08-28 | Takeda Chem Ind Ltd | 水溶解性が改善された医薬組成物 |
| WO2002047723A1 (fr) * | 2000-12-11 | 2002-06-20 | Takeda Chemical Industries, Ltd. | Compositions medicamenteuses presentant une meilleure hydrosolubilite |
-
2003
- 2003-01-09 KR KR10-2004-7010774A patent/KR20040081123A/ko not_active Application Discontinuation
- 2003-01-09 NZ NZ533893A patent/NZ533893A/en unknown
- 2003-01-09 EP EP03701037A patent/EP1471064A4/en not_active Withdrawn
- 2003-01-09 CA CA002472419A patent/CA2472419A1/en not_active Abandoned
- 2003-01-09 US US10/500,839 patent/US20050020634A1/en not_active Abandoned
- 2003-01-09 PL PL03371319A patent/PL371319A1/pl unknown
- 2003-01-09 CN CNA038021706A patent/CN1615305A/zh active Pending
- 2003-01-09 IL IL16281003A patent/IL162810A0/xx unknown
- 2003-01-09 WO PCT/JP2003/000112 patent/WO2003059900A1/ja not_active Application Discontinuation
- 2003-01-09 AU AU2003202488A patent/AU2003202488A1/en not_active Abandoned
-
2004
- 2004-08-10 NO NO20043349A patent/NO20043349L/no not_active Application Discontinuation
-
2007
- 2007-03-26 US US11/728,550 patent/US20070179154A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| KR20040081123A (ko) | 2004-09-20 |
| EP1471064A4 (en) | 2005-04-27 |
| EP1471064A1 (en) | 2004-10-27 |
| US20070179154A1 (en) | 2007-08-02 |
| IL162810A0 (en) | 2005-11-20 |
| NO20043349L (no) | 2004-10-05 |
| CN1615305A (zh) | 2005-05-11 |
| AU2003202488A1 (en) | 2003-07-30 |
| NZ533893A (en) | 2006-06-30 |
| WO2003059900A1 (fr) | 2003-07-24 |
| US20050020634A1 (en) | 2005-01-27 |
| CA2472419A1 (en) | 2003-07-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20040930A2 (en) | Acyl-4-carboxyphenylurea derivatives, method for production and use thereof | |
| IL191926A0 (en) | Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof | |
| AU2003282094A1 (en) | Novel dihydroxy-methylphenyl derivatives, method for the production and use thereof as medicaments | |
| PL378065A1 (pl) | Podstawione związki N-aryloheterocykliczne, sposób ich wytwarzania oraz ich zastosowanie jako środków leczniczych | |
| IL215617A0 (en) | Substituted pyrrolo-pyrazole derivatives and process for their preparation | |
| HK1046681A1 (en) | 6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use | |
| PL371319A1 (pl) | Pochodne kumaryny, sposób ich wytwarzania i ich zastosowanie | |
| IL196010A0 (en) | Pyrazole derivatives and process for the production thereof | |
| HK1085462A1 (zh) | 哌啶衍生物、其製備方法和應用 | |
| IL173289A0 (en) | Substituted thiazole-benzoisothiazole dioxide derivatives, method for the production thereof and use of the same | |
| HK1081965A1 (en) | Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same | |
| HK1075650A1 (en) | Acyl-3-carboxyphenylurea derivatives, method for production and use thereof | |
| PL374528A1 (pl) | Nowe koniugaty efektorowe, sposób ich wytwarzaniai ich farmaceutyczne zastosowanie | |
| PL377741A1 (pl) | Pochodne diarylocykloalkilowe, sposób ich wytwarzania i ich zastosowanie jako środka leczniczego | |
| IL174975A0 (en) | 2-phenyl-benzofuran derivatives, method for the production thereof and their use | |
| TWI318211B (en) | Novel derivatives of 4a, 5, 9, 10, 11, 12-hexahydrobenzofuro [3a, 2, 2] [2] -benzazepine, method for the production thereof and use thereof in the production of medicaments | |
| AU2003273585A1 (en) | Copolyether and process for production thereof | |
| IL173447A0 (en) | Substituted benzoylureido-o-benzoylamides, method for the production thereof and use of the same | |
| AU2003292820A1 (en) | 4-amino-5-methylpyrazole derivatives and process for production thereof | |
| AU2003264894A8 (en) | Novel method for preparing alpha-glycosylceramides, novel alpha-glycosylceramide derivatives and their uses | |
| IL157793A0 (en) | Caloporoside derivatives, methods for the production thereof and their use | |
| AU2002333449A1 (en) | C2-substituted indane-1-ols and their derivatives, method for their production and their use as medicaments | |
| AU2795202A (en) | Klainetin and derivatives thereof, method for their production and the use of the same | |
| AU2002339519A1 (en) | Coniosulphides and their derivatives, method for their production and use as medicaments | |
| AU2002336983A1 (en) | C2-disubstituted Indane-1-ones and their derivatives, method for their production and their use as medicaments |